Is SynergyRx GLP-1 Legitimate? Platform Lists Compounded Semaglutide at $200 With Oral Tablet Options
Direct Meds GLP-1 Medications Platform Maintains LegitScript Certification as New Year Weight Loss Interest Peaks Amid Compounding Regulatory Shifts
Best Peptides for Boosting Growth Hormone: ReadyRx Lists Prescription Sermorelin in Injectable and Needle-Free Formats for 2026
Best Fat Burner For Men 2026: Effective Fat Burning Supplements For Men’s Belly Fat Launched By Wolfson Brands Ltd
Best Semaglutide Options for 2026: New Oral Wegovy Pill Approved by FDA as Patients Compare Injectable and Compounded Access Pathways
Immunotherapy device intended to safely filter-out IL-6 cytokine through novel subtractive therapy Initiation of pre-clinical program is critical first step...
Veris remote digital healthcare platform to utilize first intelligent implantable vascular access port with biologic sensors and wireless communication to...
AUSTIN, Texas, Sept. 21, 2021 /PRNewswire/ -- The CSD Unites Community Foundation, a division of Communication Service for the Deaf, is seeking...
SURREY, BC / ACCESSWIRE / September 21, 2021 / Eversio Wellness Ltd. ("Eversio" or the "Company"), a mushroom wellness company,...
Strong Demand and Expanded Product Offerings Push August to Record SalesDENVER, CO / ACCESSWIRE / September 21, 2021 / Leafbuyer...
HAMILTON, BERMUDA / ACCESSWIRE / September 21, 2021 / Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to addressing unmet medical...
LAS VEGAS, NV / ACCESSWIRE / September 21, 2021 / Planet 13 Holdings Inc. (CSE:PLTH)(OTCQX:PLNHF) ("Planet 13" or the "Company"),...
An Internationally Recognized Authority in Dry Eye Disease, Dr. Tauber has Participated in over 140 Research Studies as Principal Investigator...
SAN DIEGO, CA, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye”), a biopharmaceutical company developing proprietary...
New York, NY, Sept. 21, 2021 (GLOBE NEWSWIRE) -- The C3 Summit is a renowned gathering that fosters US-Arab Healthcare...
SYDNEY, Australia, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology...
Dr. Rønø has developed Evaxion's pre-clinical and early clinical oncology pipelineNewly-created Chief Scientific Officer role strengthens Evaxion's leadership teamCOPENHAGEN, Denmark,...
Loughborough, England, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing...
SAN DIEGO, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel,...
33 early and late-stage clinical programs across modalities and innovative discovery platformsUniquely positioned to lead in Alzheimer’s disease with ADUHELM®...
NEW YORK, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) (“Brooklyn”), a biopharmaceutical company focused on...
NEW YORK, Sept. 21, 2021 (GLOBE NEWSWIRE) -- LifeSci Partners, a life-sciences focused consultancy, today announced that it has entered...
Peer-Reviewed Paper is Largest Real-World Data Set of TMS Seizure Risk Across Device ManufacturersMALVERN, Pa., Sept. 21, 2021 (GLOBE NEWSWIRE)...
Live fireside chat with C. Russell Trenary, President and CEO of Outlook Therapeutics on Tuesday, September 28 at 2:00 PM...
Company will also host key opinion leader webinar on Friday, October 1 at 10:00am ET, to discuss Phase 1 healthy...
